---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-071954"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:07:26.184619+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Q4 2025 sales $64.5M (+16%), EPS $0.68 (+39%), raises dividend 25%

## Summary
- Q4 2025 sales $64.5M (+16% YoY, +15% organic); diluted EPS $0.68 (+39%).
- Gross margin 71.7% (+240 bps); operating income $18.8M (+47%).
- Quarterly dividend increased 25% to $0.25/share; payable March 26, 2026 to holders of record March 12, 2026.
- Board authorized $100M share repurchase program, expiring February 18, 2027.
- FY2026 guidance: sales mid $280M (+12%), adj. op. income +21%, adj. EPS +22%.

## SEC filing metadata
- accession: 0001193125-26-071954
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000119312526071954/0001193125-26-071954-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000119312526071954/d23187d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-071954
- JSON: https://secwatch.observer/filing/0001193125-26-071954.json
- Plain text: https://secwatch.observer/filing/0001193125-26-071954.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.